SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-010990
Filing Date
2023-01-19
Accepted
2023-01-19 16:35:32
Documents
15
Period of Report
2023-01-19
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d450299d8k.htm   iXBRL 8-K 41701
2 EX-3.1 d450299dex31.htm EX-3.1 5660
3 EX-3.2 d450299dex32.htm EX-3.2 70831
4 EX-99.1 d450299dex991.htm EX-99.1 8974
  Complete submission text file 0001193125-23-010990.txt   278717

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA aveo-20230119.xsd EX-101.SCH 2854
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE aveo-20230119_lab.xml EX-101.LAB 17981
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aveo-20230119_pre.xml EX-101.PRE 11261
9 EXTRACTED XBRL INSTANCE DOCUMENT d450299d8k_htm.xml XML 3472
Mailing Address 30 WINTER STREET BOSTON MA 02108
Business Address 30 WINTER STREET BOSTON MA 02108 857-400-0101
AVEO PHARMACEUTICALS, INC. (Filer) CIK: 0001325879 (see all company filings)

IRS No.: 043581650 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34655 | Film No.: 23537822
SIC: 2834 Pharmaceutical Preparations